Yahoo Web Search

    • BCLI: Phase 3 ALS Data Due Soon…

      Zacks Small Cap Research via Yahoo Finance· 7 days ago

      BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is currently conducting a Phase 3 clinical trial of NurOwn® in patients with amyotrophic lateral...

    • LTRN: Reviving Failed Oncology Drugs with AI

      Zacks Small Cap Research via Yahoo Finance· 3 days ago

      Lantern is a new type of drug development company employing artificial intelligence and big data to identify critical biomarkers and relevant indications...